Valuation (79%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.68 | N/A |
| PEG Ratio (TTM) | -1.62 | N/A |
| P/S Ratio (TTM) | 0.91 | N/A |
| P/B Ratio (TTM) | 2.98 | N/A |
| P/FCF Ratio (TTM) | 7.38 | N/A |
| Price to 5YR AVG Earnings Ratio | 0.02 | N/A |
| Price to 5YR AVG FCF Ratio | 0.02 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 6.51% | N/A |
| ROE (TTM) | 19.66% | N/A |
| Net Profit Margin (TTM) | 7.02% | N/A |
| ROIC 5YR AVG | 17.97% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 4.91% | 24.51% | -4.29% |
| Revenue | 3.87% | 10.78% | 10.15% |
| Net Income | 4.43% | 25.62% | 18.92% |
| Cash Flow | 225.93% | 60.94% | 63.25% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.31 | N/A |
| Quick Ratio (TTM) | 0.91 | N/A |
| D/E Ratio (TTM) | 1.07 | N/A |
| Interest Coverage (TTM) | 9.00 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.38 | N/A |
| LTL to 5YR AVG FCF | 8.12 | N/A |
| Shares Outstanding Growth 5YR AVG | 100.00% | N/A |